BB Biotech’s Alder Biopharmaceuticals ALDR Stock Holding History

BB Biotech’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$37.8M	Hold	2,766,008	–	–	0.95%	26
2018 Q4	$28.4M	Buy	2,766,008 +500,000	+22%	+$6.4M	0.91%	25
2018 Q3	$37.7M	Hold	2,266,008	–	–	1%	26
2018 Q2	$35.8M	Hold	2,266,008	–	–	1.03%	24
2018 Q1	$28.8M	Hold	2,266,008	–	–	0.8%	25
2017 Q4	$25.9M	Hold	2,266,008	–	–	0.73%	23
2017 Q3	$27.8M	Buy	2,266,008 +325,000	+17%	+$3.39M	0.77%	23
2017 Q2	$22.2M	Buy	1,941,008 +255,858	+15%	+$4.73M	0.68%	24
2017 Q1	$35.1M	Hold	1,685,150	–	–	1.15%	20
2016 Q4	$35.1M	Hold	1,685,150	–	–	1.3%	19
2016 Q3	$55.2M	Hold	1,685,150	–	–	1.94%	14
2016 Q2	$42.1M	Buy	1,685,150 +175,000	+12%	+$4.73M	1.66%	17
2016 Q1	$37M	Hold	1,510,150	–	–	1.47%	17
2015 Q4	$49.9M	Hold	1,510,150	–	–	1.41%	18
2015 Q3	$49.5M	Buy	1,510,150 +355,000	+31%	+$15.1M	1.57%	18
2015 Q2	$61.2M	Buy	+1,155,150	New	+$42M	1.66%	17

Other funds holding ALDR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BB Biotech's ALDR Position: Q1 2019 in Review

BB Biotech held its Alder Biopharmaceuticals (ALDR) position steady in Q1 2019 at 2,766,008 shares worth $37.8M. The position accounts for 0.95% of the portfolio, ranked #26.

BB Biotech first reported a position in ALDR in Q2 2015 and has held it in 16 quarters since. The position peaked at $61.2M in Q2 2015. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

BB Biotech held 2,766,008 shares of Alder Biopharmaceuticals worth $37.8M as of Q1 2019.
BB Biotech left its Alder Biopharmaceuticals share count unchanged in Q1 2019.
Alder Biopharmaceuticals made up 0.95% of BB Biotech's portfolio in Q1 2019, its #26 holding.
BB Biotech first reported a position in Alder Biopharmaceuticals in Q2 2015 and has held it in 16 quarters since.
BB Biotech's Alder Biopharmaceuticals position peaked at $61.2M in Q2 2015.
123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.